Connection

Gary Gilkeson to Lupus Nephritis

Back to Details
This is a "connection" page, showing publications Gary Gilkeson has written about Lupus Nephritis.
Gary Gilkeson
Connection Strength
5.064
Lupus Nephritis
  1. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice. PLoS One. 2020; 15(3):e0230499.
    View in: PubMed
    Score: 0.587
  2. Estrogen receptor alpha modulates mesangial cell responses to toll-like receptor ligands. Am J Med Sci. 2014 Dec; 348(6):492-500.
    View in: PubMed
    Score: 0.407
  3. NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. Lupus. 2013 Nov; 22(13):1361-70.
    View in: PubMed
    Score: 0.376
  4. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS One. 2013; 8(5):e64650.
    View in: PubMed
    Score: 0.366
  5. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 2011; 13(6):250.
    View in: PubMed
    Score: 0.332
  6. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
    View in: PubMed
    Score: 0.312
  7. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum. 2008 Jan; 58(1):263-72.
    View in: PubMed
    Score: 0.252
  8. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur J Immunol. 2006 May; 36(5):1296-308.
    View in: PubMed
    Score: 0.224
  9. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int. 2004 Jan; 65(1):129-38.
    View in: PubMed
    Score: 0.191
  10. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB ? NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis Rheumatol. 2021 08; 73(8):1478-1488.
    View in: PubMed
    Score: 0.160
  11. Novel mechanism for estrogen receptor alpha modulation of murine lupus. J Autoimmun. 2019 02; 97:59-69.
    View in: PubMed
    Score: 0.134
  12. Soluble CD16 in the treatment of murine lupus nephritis. Clin Immunol Immunopathol. 1998 Jul; 88(1):91-5.
    View in: PubMed
    Score: 0.130
  13. Differences in V kappa gene utilization and VH CDR3 sequence among anti-DNA from C3H-lpr mice and lupus mice with nephritis. Eur J Immunol. 1996 Sep; 26(9):2225-33.
    View in: PubMed
    Score: 0.115
  14. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 1996 Jun; 39(6):894-903.
    View in: PubMed
    Score: 0.113
  15. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med. 1996 Apr 01; 183(4):1389-97.
    View in: PubMed
    Score: 0.111
  16. The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol. 1995 Jul; 76(1 Pt 1):59-67.
    View in: PubMed
    Score: 0.106
  17. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol. 2014 Nov; 33(11):1611-9.
    View in: PubMed
    Score: 0.100
  18. Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. Clin Immunol Immunopathol. 1993 Sep; 68(3):283-92.
    View in: PubMed
    Score: 0.093
  19. ABIN1 dysfunction as a genetic basis for lupus nephritis. J Am Soc Nephrol. 2013 Nov; 24(11):1743-54.
    View in: PubMed
    Score: 0.093
  20. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun. 2012 Apr; 13(3):232-8.
    View in: PubMed
    Score: 0.083
  21. The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition. Mol Immunol. 2011 Oct; 49(1-2):317-23.
    View in: PubMed
    Score: 0.082
  22. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clin Exp Immunol. 2010 Nov; 162(2):362-71.
    View in: PubMed
    Score: 0.076
  23. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus. 2010 Nov; 19(13):1502-14.
    View in: PubMed
    Score: 0.075
  24. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. 2009 Jul; 10(5):470-7.
    View in: PubMed
    Score: 0.069
  25. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J Immunol. 2008 Jan 15; 180(2):1231-8.
    View in: PubMed
    Score: 0.063
  26. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005 Nov 24; 353(21):2219-28.
    View in: PubMed
    Score: 0.054
  27. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol. 2004 Mar 15; 172(6):3913-21.
    View in: PubMed
    Score: 0.048
  28. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999 Nov-Dec; 111(6):611-21.
    View in: PubMed
    Score: 0.036
  29. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest. 1999 Jun; 103(12):1685-95.
    View in: PubMed
    Score: 0.035
  30. Detection of glomerular-binding immune elements in murine lupus using a tissue-based ELISA. Clin Exp Immunol. 1993 Mar; 91(3):449-55.
    View in: PubMed
    Score: 0.023
  31. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. 2012 Nov; 64(11):3687-94.
    View in: PubMed
    Score: 0.022
  32. Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney. Clin Immunol. 2012 Dec; 145(3):201-8.
    View in: PubMed
    Score: 0.022
  33. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011 Oct; 70(10):1752-7.
    View in: PubMed
    Score: 0.020
  34. A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis. Arthritis Res Ther. 2010; 12(6):R212.
    View in: PubMed
    Score: 0.019
  35. Total serum IgE levels in systemic lupus erythematosus and associations with childhood onset allergies. Lupus. 2010 Dec; 19(14):1614-22.
    View in: PubMed
    Score: 0.019
  36. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010 Aug; 69(8):1423-9.
    View in: PubMed
    Score: 0.019
  37. Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice. Clin Exp Immunol. 2010 May; 160(2):275-82.
    View in: PubMed
    Score: 0.018
  38. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis. 2010 Jul; 69(7):1329-32.
    View in: PubMed
    Score: 0.018
  39. Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun. 2009 Jul; 10(5):517-24.
    View in: PubMed
    Score: 0.017
  40. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene. J Investig Med. 2008 Oct; 56(7):911-9.
    View in: PubMed
    Score: 0.017
  41. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. J Immunol. 2005 Apr 15; 174(8):5065-73.
    View in: PubMed
    Score: 0.013
  42. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A. 2000 Jun 06; 97(12):6670-5.
    View in: PubMed
    Score: 0.009
  43. Systemic lupus erythematosus. Diagnosis and treatment. Med Clin North Am. 1997 Jan; 81(1):113-28.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.